These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1627192)

  • 1. Acute toxicity studies of sertaconazole.
    Grau MT; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):725-6. PubMed ID: 1627192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute toxicity and maximum tolerable dose of sertaconazole in repeated administration studies.
    Romero A; Villamayor F; Grau MT; Sacristán A; Ortíz JA
    Arzneimittelforschung; 1992 May; 42(5A):727-32. PubMed ID: 1627193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic toxicity studies of sertaconazole after oral administration to rats and ferrets.
    Romero A; Villamayor F; Grau MT; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):732-8. PubMed ID: 1627194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal tolerance and phototoxicity studies of sertaconazole.
    Grau MT; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):746-7. PubMed ID: 1627197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of labelled sertaconazole after dermal application.
    Agut J; Moren M; Rego M; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):748-51. PubMed ID: 1627198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproduction toxicity of sertaconazole. Segment II (teratology) and Segment III (peri-postnatal toxicity).
    Romero A; Grau MT; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):739-42. PubMed ID: 1627195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity studies on sertaconazole.
    Romero A; Palacín C; Mosesso P; Hodson-Walker G; Marcos R; Batiste-Alentorn M; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):743-5. PubMed ID: 1627196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration.
    Farré M; Ugena B; Badenas JM; Márquez M; Roset P; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):752-4. PubMed ID: 1627199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses.
    Alomar C; Bassas S; Casas M; Crespo V; Ferrándiz C; Fonseca E; Hernández B; Noguera J; Pedragosa R; Peyrí J
    Arzneimittelforschung; 1992 May; 42(5A):767-73. PubMed ID: 1627204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of sertaconazole.
    Drouhet E; Dupont B
    Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimycotic activity of (benzo[b]thienyl)methyl ethers of 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol and of (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime.
    Raga MM; Moreno-Mañas M; Cuberes MR; Palacín C; Castelló JM; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):691-4. PubMed ID: 1627184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis.
    Pedragosa R; González B; Martín M; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):760-3. PubMed ID: 1627202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses.
    Romaguera C; Herrero E; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):754-6. PubMed ID: 1627200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of sertaconazole in experimental dermatophytosis in guinea pigs.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):714-8. PubMed ID: 1627189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor.
    Nasarre J; Umbert P; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):764-7. PubMed ID: 1627203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity studies of ebrotidine.
    Grau MT; Romero A; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):490-1. PubMed ID: 9205750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
    Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans.
    Umbert P; Nasarre J; Bello A; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):757-60. PubMed ID: 1627201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.